The move to decentralized clinical trials for CNS and psychiatry has accelerated, and as the study landscape shifts, it’s more important than ever to know the ins and outs of preparing for IRB review. By developing an informed strategy, review can be optimized, making the process smoother while providing clean, robust data.
In this white paper, readers will learn:
- How to develop a comprehensive communication plan
- Special considerations for the informed consent process
- When to consider IRB requirements and engage with regulatory bodies
- What to include in thorough staff training protocols